SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-002816
Filing Date
2021-02-05
Accepted
2021-02-05 17:15:00
Documents
5
Period of Report
2021-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 37699
2 ex1-1.htm EX-1.1 274730
3 ex5-1.htm EX-5.1 11409
4 ex99-1.htm EX-99.1 16003
5 ex5-1_001.jpg GRAPHIC 3594
  Complete submission text file 0001493152-21-002816.txt   346187
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 21597207
SIC: 2835 In Vitro & In Vivo Diagnostic Substances